A citation-based method for searching scientific literature

Fukiko Kawai-Kitahata, Yasuhiro Asahina, Shinji Tanaka, Sei Kakinuma, Miyako Murakawa, Sayuri Nitta, Takako Watanabe, Satoshi Otani, Miki Taniguchi, Fumio Goto, Hiroko Nagata, Shun Kaneko, Megumi Tasaka-Fujita, Yuki Nishimura-Sakurai, Seishin Azuma, Yasuhiro Itsui, Mina Nakagawa, Minoru Tanabe, Shinichi Takano, Mitsuharu Fukasawa, Minoru Sakamoto, Shinya Maekawa, Nobuyuki Enomoto, Mamoru Watanabe. J Gastroenterol 2016
Times Cited: 60







List of co-cited articles
587 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma.
Wing-Kin Sung, Hancheng Zheng, Shuyu Li, Ronghua Chen, Xiao Liu, Yingrui Li, Nikki P Lee, Wah H Lee, Pramila N Ariyaratne, Chandana Tennakoon,[...]. Nat Genet 2012
553
43

High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions.
Jean Charles Nault, Maxime Mallet, Camilla Pilati, Julien Calderaro, Paulette Bioulac-Sage, Christophe Laurent, Alexis Laurent, Daniel Cherqui, Charles Balabaud, Jessica Zucman-Rossi. Nat Commun 2013
373
43

Trans-ancestry mutational landscape of hepatocellular carcinoma genomes.
Yasushi Totoki, Kenji Tatsuno, Kyle R Covington, Hiroki Ueda, Chad J Creighton, Mamoru Kato, Shingo Tsuji, Lawrence A Donehower, Betty L Slagle, Hiromi Nakamura,[...]. Nat Genet 2014
420
40

Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets.
Kornelius Schulze, Sandrine Imbeaud, Eric Letouzé, Ludmil B Alexandrov, Julien Calderaro, Sandra Rebouissou, Gabrielle Couchy, Clément Meiller, Jayendra Shinde, Frederic Soysouvanh,[...]. Nat Genet 2015
799
31

Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis.
Jean Charles Nault, Julien Calderaro, Luca Di Tommaso, Charles Balabaud, Elie Serge Zafrani, Paulette Bioulac-Sage, Massimo Roncalli, Jessica Zucman-Rossi. Hepatology 2014
174
30

TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal.
Patrick J Killela, Zachary J Reitman, Yuchen Jiao, Chetan Bettegowda, Nishant Agrawal, Luis A Diaz, Allan H Friedman, Henry Friedman, Gary L Gallia, Beppino C Giovanella,[...]. Proc Natl Acad Sci U S A 2013
860
26

Genetic Landscape and Biomarkers of Hepatocellular Carcinoma.
Jessica Zucman-Rossi, Augusto Villanueva, Jean-Charles Nault, Josep M Llovet. Gastroenterology 2015
561
26

Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators.
Akihiro Fujimoto, Yasushi Totoki, Tetsuo Abe, Keith A Boroevich, Fumie Hosoda, Ha Hai Nguyen, Masayuki Aoki, Naoya Hosono, Michiaki Kubo, Fuyuki Miya,[...]. Nat Genet 2012
600
25

Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma.
Cécile Guichard, Giuliana Amaddeo, Sandrine Imbeaud, Yannick Ladeiro, Laura Pelletier, Ichrafe Ben Maad, Julien Calderaro, Paulette Bioulac-Sage, Mélanie Letexier, Françoise Degos,[...]. Nat Genet 2012
882
25

TERT promoter mutations in familial and sporadic melanoma.
Susanne Horn, Adina Figl, P Sivaramakrishna Rachakonda, Christine Fischer, Antje Sucker, Andreas Gast, Stephanie Kadel, Iris Moll, Eduardo Nagore, Kari Hemminki,[...]. Science 2013
23

Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma.
Ling-Hao Zhao, Xiao Liu, He-Xin Yan, Wei-Yang Li, Xi Zeng, Yuan Yang, Jie Zhao, Shi-Ping Liu, Xue-Han Zhuang, Chuan Lin,[...]. Nat Commun 2016
131
23

Highly recurrent TERT promoter mutations in human melanoma.
Franklin W Huang, Eran Hodis, Mary Jue Xu, Gregory V Kryukov, Lynda Chin, Levi A Garraway. Science 2013
21

TERT promoter mutation in resectable hepatocellular carcinomas: a strong association with hepatitis C infection and absence of hepatitis B infection.
Yu-Ling Chen, Yung-Ming Jeng, Chih-Ning Chang, Hsin-Jung Lee, Hey-Chi Hsu, Po-Lin Lai, Ray-Hwang Yuan. Int J Surg 2014
41
31

Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma.
Zhengyan Kan, Hancheng Zheng, Xiao Liu, Shuyu Li, Thomas D Barber, Zhuolin Gong, Huan Gao, Ke Hao, Melinda D Willard, Jiangchun Xu,[...]. Genome Res 2013
331
20

Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer.
Akihiro Fujimoto, Mayuko Furuta, Yasushi Totoki, Tatsuhiko Tsunoda, Mamoru Kato, Yuichi Shiraishi, Hiroko Tanaka, Hiroaki Taniguchi, Yoshiiku Kawakami, Masaki Ueno,[...]. Nat Genet 2016
356
20

TERT promoter mutations: gatekeeper and driver of hepatocellular carcinoma.
Roser Pinyol, Victoria Tovar, Josep M Llovet. J Hepatol 2014
32
34

Frequency of TERT promoter mutations in primary tumors of the liver.
Alexander Quaas, Theresa Oldopp, Lars Tharun, Catina Klingenfeld, Till Krech, Guido Sauter, Tobias J Grob. Virchows Arch 2014
38
26

Sorafenib in advanced hepatocellular carcinoma.
Josep M Llovet, Sergio Ricci, Vincenzo Mazzaferro, Philip Hilgard, Edward Gane, Jean-Frédéric Blanc, Andre Cosme de Oliveira, Armando Santoro, Jean-Luc Raoul, Alejandro Forner,[...]. N Engl J Med 2008
16

TERT promoter mutations in primary liver tumors.
Jean-Charles Nault, Jessica Zucman-Rossi. Clin Res Hepatol Gastroenterol 2016
53
18

Deep sequencing of the hepatitis B virus in hepatocellular carcinoma patients reveals enriched integration events, structural alterations and sequence variations.
Soo Ting Toh, Yu Jin, Lizhen Liu, Jingbo Wang, Farbod Babrzadeh, Baback Gharizadeh, Mostafa Ronaghi, Han Chong Toh, Pierce Kah-Hoe Chow, Alexander Y-F Chung,[...]. Carcinogenesis 2013
77
15


Frequency of TERT promoter mutations in human cancers.
João Vinagre, Ana Almeida, Helena Pópulo, Rui Batista, Joana Lyra, Vasco Pinto, Ricardo Coelho, Ricardo Celestino, Hugo Prazeres, Luis Lima,[...]. Nat Commun 2013
519
15

Tumor specific mutations in TERT promoter and CTNNB1 gene in hepatitis B and hepatitis C related hepatocellular carcinoma.
Francesca Pezzuto, Francesco Izzo, Luigi Buonaguro, Clorinda Annunziata, Fabiana Tatangelo, Gerardo Botti, Franco M Buonaguro, Maria Lina Tornesello. Oncotarget 2016
30
30

Identification of driver genes in hepatocellular carcinoma by exome sequencing.
Sean P Cleary, William R Jeck, Xiaobei Zhao, Kui Chen, Sara R Selitsky, Gleb L Savich, Ting-Xu Tan, Michael C Wu, Gad Getz, Michael S Lawrence,[...]. Hepatology 2013
197
15

Specific association of human telomerase activity with immortal cells and cancer.
N W Kim, M A Piatyszek, K R Prowse, C B Harley, M D West, P L Ho, G M Coviello, W E Wright, S L Weinrich, J W Shay. Science 1994
13

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.
Jacques Ferlay, Isabelle Soerjomataram, Rajesh Dikshit, Sultan Eser, Colin Mathers, Marise Rebelo, Donald Maxwell Parkin, David Forman, Freddie Bray. Int J Cancer 2015
13

Whole-genome mutational landscape of liver cancers displaying biliary phenotype reveals hepatitis impact and molecular diversity.
Akihiro Fujimoto, Mayuko Furuta, Yuichi Shiraishi, Kunihito Gotoh, Yoshiiku Kawakami, Koji Arihiro, Toru Nakamura, Masaki Ueno, Shun-ichi Ariizumi, Ha Hai Nguyen,[...]. Nat Commun 2015
119
13

Telomerase reverse transcriptase promoter mutations in hepatitis B virus-associated hepatocellular carcinoma.
Xunjun Yang, Xiuchan Guo, Yao Chen, Guorong Chen, Yin Ma, Kate Huang, Yuning Zhang, Qiongya Zhao, Cheryl A Winkler, Ping An,[...]. Oncotarget 2016
20
40

Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer.
Robert J A Bell, H Tomas Rube, Alex Kreig, Andrew Mancini, Shaun D Fouse, Raman P Nagarajan, Serah Choi, Chibo Hong, Daniel He, Melike Pekmezci,[...]. Science 2015
294
13

Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene.
Patrizia Paterlini-Bréchot, Kenichi Saigo, Yoshiki Murakami, Mounia Chami, Devrim Gozuacik, Claude Mugnier, David Lagorce, Christian Bréchot. Oncogene 2003
205
13

Recurrent TERT promoter mutations identified in a large-scale study of multiple tumour types are associated with increased TERT expression and telomerase activation.
Dong-Sheng Huang, Zhaohui Wang, Xu-Jun He, Bill H Diplas, Rui Yang, Patrick J Killela, Qun Meng, Zai-Yuan Ye, Wei Wang, Xiao-Ting Jiang,[...]. Eur J Cancer 2015
98
13

Cancer. TERT promoter mutations and telomerase reactivation in urothelial cancer.
Sumit Borah, Linghe Xi, Arthur J Zaug, Natasha M Powell, Garrett M Dancik, Scott B Cohen, James C Costello, Dan Theodorescu, Thomas R Cech. Science 2015
194
13

Characterization of the genotype and integration patterns of hepatitis B virus in early- and late-onset hepatocellular carcinoma.
Hongli Yan, Yuan Yang, Ling Zhang, Guannan Tang, YuZhao Wang, Geng Xue, Weiping Zhou, Shuhan Sun. Hepatology 2015
49
16


The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas.
T Liu, N Wang, J Cao, A Sofiadis, A Dinets, J Zedenius, C Larsson, D Xu. Oncogene 2014
158
11

Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections.
Maria Lina Tornesello, Luigi Buonaguro, Fabiana Tatangelo, Gerardo Botti, Francesco Izzo, Franco M Buonaguro. Genomics 2013
85
11

Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma.
Jian Huang, Qing Deng, Qun Wang, Kun-Yu Li, Ji-Hong Dai, Niu Li, Zhi-Dong Zhu, Bo Zhou, Xiao-Yan Liu, Rui-Fang Liu,[...]. Nat Genet 2012
271
11

Mechanisms of HBV-induced hepatocellular carcinoma.
Massimo Levrero, Jessica Zucman-Rossi. J Hepatol 2016
351
11

TERT promoter mutations and chromosome 8p loss are characteristic of nonalcoholic fatty liver disease-related hepatocellular carcinoma.
Soo Ki Kim, Yoshihide Ueda, Etsuro Hatano, Nobuyuki Kakiuchi, Haruhiko Takeda, Tomoyuki Goto, Takahiro Shimizu, Kenichi Yoshida, Yoshihiro Ikura, Yuichi Shiraishi,[...]. Int J Cancer 2016
24
29


The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients.
Zhaoshi Jiang, Suchit Jhunjhunwala, Jinfeng Liu, Peter M Haverty, Michael I Kennemer, Yinghui Guan, William Lee, Paolo Carnevali, Jeremy Stinson, Stephanie Johnson,[...]. Genome Res 2012
184
11

TERT promoter mutations in cancer development.
Barbara Heidenreich, P Sivaramakrishna Rachakonda, Kari Hemminki, Rajiv Kumar. Curr Opin Genet Dev 2014
144
10

Genomic portrait of resectable hepatocellular carcinomas: implications of RB1 and FGF19 aberrations for patient stratification.
Sung-Min Ahn, Se Jin Jang, Ju Hyun Shim, Deokhoon Kim, Seung-Mo Hong, Chang Ohk Sung, Daehyun Baek, Farhan Haq, Adnan Ahmad Ansari, Sun Young Lee,[...]. Hepatology 2014
223
10

Viral-human chimeric transcript predisposes risk to liver cancer development and progression.
Chi-Chiu Lau, Tingting Sun, Arthur K K Ching, Mian He, Jing-Woei Li, Alissa M Wong, Ngai Na Co, Anthony W H Chan, Pik-Shan Li, Raymond W M Lung,[...]. Cancer Cell 2014
171
10

Integrated analysis of whole genome and transcriptome sequencing reveals diverse transcriptomic aberrations driven by somatic genomic changes in liver cancers.
Yuichi Shiraishi, Akihiro Fujimoto, Mayuko Furuta, Hiroko Tanaka, Ken-ichi Chiba, Keith A Boroevich, Tetsuo Abe, Yoshiiku Kawakami, Masaki Ueno, Kunihito Gotoh,[...]. PLoS One 2014
50
12

TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine.
Isaac Kinde, Enrico Munari, Sheila F Faraj, Ralph H Hruban, Mark Schoenberg, Trinity Bivalacqua, Mohamad Allaf, Simeon Springer, Yuxuan Wang, Luis A Diaz,[...]. Cancer Res 2013
166
10

Cancer-associated TERT promoter mutations abrogate telomerase silencing.
Kunitoshi Chiba, Joshua Z Johnson, Jacob M Vogan, Tina Wagner, John M Boyle, Dirk Hockemeyer. Elife 2015
147
10

Telomerase activation by genomic rearrangements in high-risk neuroblastoma.
Martin Peifer, Falk Hertwig, Frederik Roels, Daniel Dreidax, Moritz Gartlgruber, Roopika Menon, Andrea Krämer, Justin L Roncaioli, Frederik Sand, Johannes M Heuckmann,[...]. Nature 2015
278
10

Recurrent targeted genes of hepatitis B virus in the liver cancer genomes identified by a next-generation sequencing-based approach.
Dong Ding, Xiaoyan Lou, Dasong Hua, Wei Yu, Lisha Li, Jun Wang, Feng Gao, Na Zhao, Guoping Ren, Lanjuan Li,[...]. PLoS Genet 2012
126
10

Frequent somatic TERT promoter mutations and CTNNB1 mutations in hepatocellular carcinoma.
Seung Eun Lee, Seong-Hwan Chang, Wook Youn Kim, So Dug Lim, Wan Seop Kim, Tea Sook Hwang, Hye Seung Han. Oncotarget 2016
20
30


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.